RecruitingNCT06433817

Spectral CT in Radiotherapy for Cervical Cancer

The Clinical Research of Spectral CT in Radiotherapy for Cervical Cancer


Sponsor

Peking Union Medical College Hospital

Enrollment

150 participants

Start Date

May 22, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study was to explore the potential application of spectral CT for radiotherapy in cervical cancer.


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is using a newer type of CT scan technology (spectral CT) to better predict how well cervical cancer will respond to chemotherapy combined with radiation treatment, potentially allowing for more personalized treatment plans. **You may be eligible if...** - You have been diagnosed with cervical cancer confirmed by pathology (biopsy) - You are being treated with concurrent chemotherapy and radiation (chemoradiotherapy) - You received spectral CT scans in both the arterial and venous phases - You had a PET/CT scan using a radioactive glucose tracer (18F-FDG) before starting treatment **You may NOT be eligible if...** - Your CT scan was not done with spectral imaging technology - You have an allergy to intravenous contrast dye - You are pregnant or could be pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONSpectral computed tomography scan

Spectral CT scans acquisition performed during the arterial phase and venous phase for cervical cancer


Locations(1)

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06433817


Related Trials